Click for best price
Parkinsons Disease Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 5651 million
|
Forecast Market size by 2029 |
US$ 8459.7 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
71 Pages |
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
This report aims to provide a comprehensive presentation of the global market for Parkinsons Disease Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Parkinsons Disease Drugs. This report contains market size and forecasts of Parkinsons Disease Drugs in global, including the following market information:
Global Parkinsons Disease Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Parkinsons Disease Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Parkinsons Disease Drugs companies in 2022 (%)
The global Parkinsons Disease Drugs market was valued at US$ 5651 million in 2022 and is projected to reach US$ 8459.7 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Parkinson Disease Drug key players include Merck, Akorn, GSK, Boehringer Ingelheim, Teva Pharmaceutical, etc.
We surveyed the Parkinsons Disease Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Parkinsons Disease Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parkinsons Disease Drugs Market Segment Percentages, by Type, 2022 (%)
Clinical
Experiment
Global Parkinsons Disease Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parkinsons Disease Drugs Market Segment Percentages, by Application, 2022 (%)
Treament
Prevention
Global Parkinsons Disease Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Parkinsons Disease Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Parkinsons Disease Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Parkinsons Disease Drugs revenues share in global market, 2022 (%)
Key companies Parkinsons Disease Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Parkinsons Disease Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Gilead Sciences
Pacira
Sun Pharmaceutical
Luye Pharma
Sigma-Tau Group
Fudan-Zhangjiang
Teva Pharmaceutical
CSPC
Novartis
Kingond Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Parkinsons Disease Drugs, market overview.
Chapter 2: Global Parkinsons Disease Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Parkinsons Disease Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Parkinsons Disease Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Parkinsons Disease Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Parkinsons Disease Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 5651 million
|
| Forecast Market size by 2029 |
US$ 8459.7 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Parkinsons Disease Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Parkinsons Disease Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Parkinsons Disease Drugs Overall Market Size
2.1 Global Parkinsons Disease Drugs Market Size: 2022 VS 2029
2.2 Global Parkinsons Disease Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Parkinsons Disease Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Parkinsons Disease Drugs Players in Global Market
3.2 Top Global Parkinsons Disease Drugs Companies Ranked by Revenue
3.3 Global Parkinsons Disease Drugs Revenue by Companies
3.4 Global Parkinsons Disease Drugs Sales by Companies
3.5 Global Parkinsons Disease Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Parkinsons Disease Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Parkinsons Disease Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Parkinsons Disease Drugs Players in Global Market
3.8.1 List of Global Tier 1 Parkinsons Disease Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Parkinsons Disease Drugs Market Size Markets, 2022 & 2029
4.1.2 Clinical
4.1.3 Experiment
4.2 By Type - Global Parkinsons Disease Drugs Revenue & Forecasts
4.2.1 By Type - Global Parkinsons Disease Drugs Revenue, 2018-2023
4.2.2 By Type - Global Parkinsons Disease Drugs Revenue, 2024-2029
4.2.3 By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Parkinsons Disease Drugs Sales & Forecasts
4.3.1 By Type - Global Parkinsons Disease Drugs Sales, 2018-2023
4.3.2 By Type - Global Parkinsons Disease Drugs Sales, 2024-2029
4.3.3 By Type - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Parkinsons Disease Drugs Market Size, 2022 & 2029
5.1.2 Treament
5.1.3 Prevention
5.2 By Application - Global Parkinsons Disease Drugs Revenue & Forecasts
5.2.1 By Application - Global Parkinsons Disease Drugs Revenue, 2018-2023
5.2.2 By Application - Global Parkinsons Disease Drugs Revenue, 2024-2029
5.2.3 By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Parkinsons Disease Drugs Sales & Forecasts
5.3.1 By Application - Global Parkinsons Disease Drugs Sales, 2018-2023
5.3.2 By Application - Global Parkinsons Disease Drugs Sales, 2024-2029
5.3.3 By Application - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Parkinsons Disease Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Parkinsons Disease Drugs Market Size, 2022 & 2029
6.2 By Region - Global Parkinsons Disease Drugs Revenue & Forecasts
6.2.1 By Region - Global Parkinsons Disease Drugs Revenue, 2018-2023
6.2.2 By Region - Global Parkinsons Disease Drugs Revenue, 2024-2029
6.2.3 By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Parkinsons Disease Drugs Sales & Forecasts
6.3.1 By Region - Global Parkinsons Disease Drugs Sales, 2018-2023
6.3.2 By Region - Global Parkinsons Disease Drugs Sales, 2024-2029
6.3.3 By Region - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Parkinsons Disease Drugs Revenue, 2018-2029
6.4.2 By Country - North America Parkinsons Disease Drugs Sales, 2018-2029
6.4.3 US Parkinsons Disease Drugs Market Size, 2018-2029
6.4.4 Canada Parkinsons Disease Drugs Market Size, 2018-2029
6.4.5 Mexico Parkinsons Disease Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Parkinsons Disease Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Parkinsons Disease Drugs Sales, 2018-2029
6.5.3 Germany Parkinsons Disease Drugs Market Size, 2018-2029
6.5.4 France Parkinsons Disease Drugs Market Size, 2018-2029
6.5.5 U.K. Parkinsons Disease Drugs Market Size, 2018-2029
6.5.6 Italy Parkinsons Disease Drugs Market Size, 2018-2029
6.5.7 Russia Parkinsons Disease Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Parkinsons Disease Drugs Market Size, 2018-2029
6.5.9 Benelux Parkinsons Disease Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Parkinsons Disease Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Parkinsons Disease Drugs Sales, 2018-2029
6.6.3 China Parkinsons Disease Drugs Market Size, 2018-2029
6.6.4 Japan Parkinsons Disease Drugs Market Size, 2018-2029
6.6.5 South Korea Parkinsons Disease Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Parkinsons Disease Drugs Market Size, 2018-2029
6.6.7 India Parkinsons Disease Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Parkinsons Disease Drugs Revenue, 2018-2029
6.7.2 By Country - South America Parkinsons Disease Drugs Sales, 2018-2029
6.7.3 Brazil Parkinsons Disease Drugs Market Size, 2018-2029
6.7.4 Argentina Parkinsons Disease Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Parkinsons Disease Drugs Sales, 2018-2029
6.8.3 Turkey Parkinsons Disease Drugs Market Size, 2018-2029
6.8.4 Israel Parkinsons Disease Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Parkinsons Disease Drugs Market Size, 2018-2029
6.8.6 UAE Parkinsons Disease Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Company Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Parkinsons Disease Drugs Major Product Offerings
7.1.4 Johnson & Johnson Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Johnson & Johnson Key News & Latest Developments
7.2 Gilead Sciences
7.2.1 Gilead Sciences Company Summary
7.2.2 Gilead Sciences Business Overview
7.2.3 Gilead Sciences Parkinsons Disease Drugs Major Product Offerings
7.2.4 Gilead Sciences Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Gilead Sciences Key News & Latest Developments
7.3 Pacira
7.3.1 Pacira Company Summary
7.3.2 Pacira Business Overview
7.3.3 Pacira Parkinsons Disease Drugs Major Product Offerings
7.3.4 Pacira Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Pacira Key News & Latest Developments
7.4 Sun Pharmaceutical
7.4.1 Sun Pharmaceutical Company Summary
7.4.2 Sun Pharmaceutical Business Overview
7.4.3 Sun Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.4.4 Sun Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Sun Pharmaceutical Key News & Latest Developments
7.5 Luye Pharma
7.5.1 Luye Pharma Company Summary
7.5.2 Luye Pharma Business Overview
7.5.3 Luye Pharma Parkinsons Disease Drugs Major Product Offerings
7.5.4 Luye Pharma Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Luye Pharma Key News & Latest Developments
7.6 Sigma-Tau Group
7.6.1 Sigma-Tau Group Company Summary
7.6.2 Sigma-Tau Group Business Overview
7.6.3 Sigma-Tau Group Parkinsons Disease Drugs Major Product Offerings
7.6.4 Sigma-Tau Group Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Sigma-Tau Group Key News & Latest Developments
7.7 Fudan-Zhangjiang
7.7.1 Fudan-Zhangjiang Company Summary
7.7.2 Fudan-Zhangjiang Business Overview
7.7.3 Fudan-Zhangjiang Parkinsons Disease Drugs Major Product Offerings
7.7.4 Fudan-Zhangjiang Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Fudan-Zhangjiang Key News & Latest Developments
7.8 Teva Pharmaceutical
7.8.1 Teva Pharmaceutical Company Summary
7.8.2 Teva Pharmaceutical Business Overview
7.8.3 Teva Pharmaceutical Parkinsons Disease Drugs Major Product Offerings
7.8.4 Teva Pharmaceutical Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Teva Pharmaceutical Key News & Latest Developments
7.9 CSPC
7.9.1 CSPC Company Summary
7.9.2 CSPC Business Overview
7.9.3 CSPC Parkinsons Disease Drugs Major Product Offerings
7.9.4 CSPC Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.9.5 CSPC Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Parkinsons Disease Drugs Major Product Offerings
7.10.4 Novartis Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Novartis Key News & Latest Developments
7.11 Kingond Pharm
7.11.1 Kingond Pharm Company Summary
7.11.2 Kingond Pharm Parkinsons Disease Drugs Business Overview
7.11.3 Kingond Pharm Parkinsons Disease Drugs Major Product Offerings
7.11.4 Kingond Pharm Parkinsons Disease Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Kingond Pharm Key News & Latest Developments
8 Global Parkinsons Disease Drugs Production Capacity, Analysis
8.1 Global Parkinsons Disease Drugs Production Capacity, 2018-2029
8.2 Parkinsons Disease Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Parkinsons Disease Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Parkinsons Disease Drugs Supply Chain Analysis
10.1 Parkinsons Disease Drugs Industry Value Chain
10.2 Parkinsons Disease Drugs Upstream Market
10.3 Parkinsons Disease Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Parkinsons Disease Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Parkinsons Disease Drugs in Global Market
Table 2. Top Parkinsons Disease Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Parkinsons Disease Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Parkinsons Disease Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Parkinsons Disease Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Parkinsons Disease Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Parkinsons Disease Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Parkinsons Disease Drugs Product Type
Table 9. List of Global Tier 1 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Parkinsons Disease Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Parkinsons Disease Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Parkinsons Disease Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Parkinsons Disease Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Parkinsons Disease Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Parkinsons Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Parkinsons Disease Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Parkinsons Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Parkinsons Disease Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Parkinsons Disease Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Parkinsons Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Parkinsons Disease Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Parkinsons Disease Drugs Sales, (K Units), 2024-2029
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Parkinsons Disease Drugs Product Offerings
Table 48. Johnson & Johnson Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Gilead Sciences Company Summary
Table 51. Gilead Sciences Parkinsons Disease Drugs Product Offerings
Table 52. Gilead Sciences Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Gilead Sciences Key News & Latest Developments
Table 54. Pacira Company Summary
Table 55. Pacira Parkinsons Disease Drugs Product Offerings
Table 56. Pacira Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Pacira Key News & Latest Developments
Table 58. Sun Pharmaceutical Company Summary
Table 59. Sun Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 60. Sun Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Sun Pharmaceutical Key News & Latest Developments
Table 62. Luye Pharma Company Summary
Table 63. Luye Pharma Parkinsons Disease Drugs Product Offerings
Table 64. Luye Pharma Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Luye Pharma Key News & Latest Developments
Table 66. Sigma-Tau Group Company Summary
Table 67. Sigma-Tau Group Parkinsons Disease Drugs Product Offerings
Table 68. Sigma-Tau Group Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Sigma-Tau Group Key News & Latest Developments
Table 70. Fudan-Zhangjiang Company Summary
Table 71. Fudan-Zhangjiang Parkinsons Disease Drugs Product Offerings
Table 72. Fudan-Zhangjiang Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Fudan-Zhangjiang Key News & Latest Developments
Table 74. Teva Pharmaceutical Company Summary
Table 75. Teva Pharmaceutical Parkinsons Disease Drugs Product Offerings
Table 76. Teva Pharmaceutical Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Teva Pharmaceutical Key News & Latest Developments
Table 78. CSPC Company Summary
Table 79. CSPC Parkinsons Disease Drugs Product Offerings
Table 80. CSPC Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. CSPC Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Parkinsons Disease Drugs Product Offerings
Table 84. Novartis Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Novartis Key News & Latest Developments
Table 86. Kingond Pharm Company Summary
Table 87. Kingond Pharm Parkinsons Disease Drugs Product Offerings
Table 88. Kingond Pharm Parkinsons Disease Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Kingond Pharm Key News & Latest Developments
Table 90. Parkinsons Disease Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 91. Global Parkinsons Disease Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Parkinsons Disease Drugs Production by Region, 2018-2023 (K Units)
Table 93. Global Parkinsons Disease Drugs Production by Region, 2024-2029 (K Units)
Table 94. Parkinsons Disease Drugs Market Opportunities & Trends in Global Market
Table 95. Parkinsons Disease Drugs Market Drivers in Global Market
Table 96. Parkinsons Disease Drugs Market Restraints in Global Market
Table 97. Parkinsons Disease Drugs Raw Materials
Table 98. Parkinsons Disease Drugs Raw Materials Suppliers in Global Market
Table 99. Typical Parkinsons Disease Drugs Downstream
Table 100. Parkinsons Disease Drugs Downstream Clients in Global Market
Table 101. Parkinsons Disease Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Parkinsons Disease Drugs Segment by Type in 2022
Figure 2. Parkinsons Disease Drugs Segment by Application in 2022
Figure 3. Global Parkinsons Disease Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Parkinsons Disease Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Parkinsons Disease Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Parkinsons Disease Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Parkinsons Disease Drugs Revenue in 2022
Figure 9. By Type - Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Parkinsons Disease Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Parkinsons Disease Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Parkinsons Disease Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 23. US Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 28. Germany Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 37. China Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Parkinsons Disease Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Parkinsons Disease Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Parkinsons Disease Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Parkinsons Disease Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Parkinsons Disease Drugs by Region, 2022 VS 2029
Figure 54. Parkinsons Disease Drugs Industry Value Chain
Figure 55. Marketing Channels
